Neogen Corporation Common Stock
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.
NEOG Overview
Sector |
Health Care |
Industry |
Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Previous Close |
$22.5600 |
Previous Close Volume |
2020000 |
Latest News
- Neogen Announces First-Quarter 2025 Results 10 Oct 2024 07:30:04
- Neogen Announces the Appointment of New Board Member 01 Oct 2024 09:00:11
- Neogen® to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference 05 Jun 2024 16:30:47
- Neogen Announces Third-Quarter Earnings Release Date 19 Mar 2024 19:46:06
- Neogen® Announces James Walter as Vice President, Global Operations 06 Feb 2024 18:01:31
- Neogen® Releases SureKill® Gel Bait Pro Applicator 17 Jan 2024 09:01:16
- Neogen® Releases Provecta® Pro Flea & Tick Collar for Dogs 15 Jan 2024 13:49:47
- Neogen Announces Second-Quarter 2024 Results 09 Jan 2024 07:27:13
- Neogen® Launches Highly Sensitive Quantitative ELISA Assay for the Detection of Walnut Allergens 30 Nov 2023 09:30:12
- Neogen® to Participate in the Piper Sandler 35th Annual Healthcare Conference 21 Nov 2023 09:00:23
- Neogen Announces Fourth-Quarter 2023 Results 27 Jul 2023 07:08:44